SALT LAKE CITY, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, has launched a new educational website providing ...

Diaz, President and CEO, Myriad Genetics. “In concert with our mission ... the company recycled 46.9 tons of plastic from its Salt Lake City laboratories. For more information about Myriad ...

Myriad Medical Supply today announced that the company has upgraded its portfolio of disposable medical products and hired David Nichols, a veteran leader in the healthcare industry, to serve ...

Myriad Genetics, Inc. has released its Quality ... the company recycled 46.9 tons of plastic from its Salt Lake City laboratories. This press release contains “forward-looking statements ...

SALT LAKE CITY, Jan. 06, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today ...

This article will explore what DLBCL is and how clinical trials can potentially lead to breakthroughs in treatment.

Results: Myriad Genetic's BRCA1/2 gene patents sparked ... threat of patent infringement action against government testing laboratories and potential impacts on public health care.

Gastric cancer diagnostics companies are Abbott, BD, Bio-Rad Laboratories, Roche, Siemens Healthineers, Thermo Fisher Scientific, Pillar Biosciences, ETC ...

At-home test kits offer a convenient way to monitor health conditions privately, using advanced technologies for accurate and ...

EYLEA HD® and EYLEA® remained the U.S. anti-VEGF category leader in 2024; aggregate U.S. net product sales were $6 billion for full-year 2024, up 1% based on preliminary (unaudited) results EYLEA HD ...

USA Esoteric Testing Market is expected to show increasing and is expected to grow at a CAGR of ~$% from 2022 to 2028 with the need for early detection & diagnosis & rapid technological advancements ...